$ACB I think a lot of the short thesis has been the continually published upcoming write down on ACB's previously foolishly high acquisitions in 2018. Yes, they will take an impairment charge. No, it will not seriously tank the stock as even my grandmother, who is dead, has heard it. These already known, "knowns "have been catalysts in driving the stock price lower. How many times have you seen a stock that was expected to have a disastrous quarter actually go up on the ER date. If you look at the previous months decline it was already discounted by the market. ACB will be no different.
  • 4
  • 7